02/14/2025 8:30 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) Singer Nicholas Jason (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 7:36 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025 4:54 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025 6:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Luther Sanjeev (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Cicala Peter (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Bristol James Arthur (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Wexler William A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 4:31 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025 4:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Ratner Elena (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/14/2025 4:01 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Ratner Elena (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ERNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/17/2024 11:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
11/14/2024 5:45 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/14/2024 5:45 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/05/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/05/2024 11:42 AM | Cherington Charles (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form ARS | |
09/27/2024 3:47 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
09/27/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 3:36 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 4:00 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024 3:32 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 4:14 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-K/A | |